| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Moderna Inc (NASDAQ: MRNA)
MRNA Technical Analysis
5
| As on 9th Jun 2023 MRNA SHARE Price closed @ 123.26 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 157.57 & Strong Sell for SHORT-TERM with Stoploss of 182.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MRNASHARE Price
| Open | 124.70 | Change | Price | % |
| High | 125.63 | 1 Day | -1.68 | -1.34 |
| Low | 122.80 | 1 Week | -4.45 | -3.48 |
| Close | 123.26 | 1 Month | -6.81 | -5.24 |
| Volume | 2201900 | 1 Year | -144.88 | -54.03 |
| 52 Week High 276.38 | 52 Week Low 117.13 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MRNA Daily Charts |
MRNA Intraday Charts |
Whats New @ Bazaartrend |
MRNA Free Analysis |
|
|
MRNA Important Levels Intraday
| RESISTANCE | 128.71 |
| RESISTANCE | 126.96 |
| RESISTANCE | 125.88 |
| RESISTANCE | 124.80 |
| SUPPORT | 121.72 |
| SUPPORT | 120.64 |
| SUPPORT | 119.56 |
| SUPPORT | 117.81 |
MRNA Forecast April 2024
| 4th UP Forecast | 323.38 |
| 3rd UP Forecast | 259.2 |
| 2nd UP Forecast | 219.53 |
| 1st UP Forecast | 179.86 |
| 1st DOWN Forecast | 66.66 |
| 2nd DOWN Forecast | 26.99 |
| 3rd DOWN Forecast | -12.68 |
| 4th DOWN Forecast | -76.86 |
MRNA Weekly Forecast
| 4th UP Forecast | 188.70 |
| 3rd UP Forecast | 167.71 |
| 2nd UP Forecast | 154.74 |
| 1st UP Forecast | 141.77 |
| 1st DOWN Forecast | 104.75 |
| 2nd DOWN Forecast | 91.78 |
| 3rd DOWN Forecast | 78.81 |
| 4th DOWN Forecast | 57.82 |
MRNA Forecast2024
| 4th UP Forecast | 416.11 |
| 3rd UP Forecast | 322.19 |
| 2nd UP Forecast | 264.14 |
| 1st UP Forecast | 206.08 |
| 1st DOWN Forecast | 40.44 |
| 2nd DOWN Forecast | -17.62 |
| 3rd DOWN Forecast | -75.67 |
| 4th DOWN Forecast | -169.59 |
Moderna Inc ( NASDAQ USA Symbol : MRNA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MRNA Business Profile
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. Address: 200 Technology Square, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service